Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
Salvatore Crisafulli, Valentina Isgrò, Laura La Corte, Fabiola Atzeni, Gianluca Trifirò
Topics & Concepts
TocilizumabCytokine stormMedicineCytokine release syndromeIntensive care medicineCoronavirusCoronavirus disease 2019 (COVID-19)DiseaseImmunologyInfectious disease (medical specialty)Internal medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCAR-T cell therapy research